Moderna to launch phase III trials for mRNA cancer vaccine
The mRNA technology used in Moderna's cancer vaccine is built off of what was used in their COVID-19 vaccine.
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020(photo credit: BRIAN SNYDER/REUTERS)
